Correlation Between Denali Therapeutics and Dianthus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Dianthus Therapeutics, you can compare the effects of market volatilities on Denali Therapeutics and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Dianthus Therapeutics.
Diversification Opportunities for Denali Therapeutics and Dianthus Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Denali and Dianthus is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Dianthus Therapeutics go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Dianthus Therapeutics
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 0.93 times more return on investment than Dianthus Therapeutics. However, Denali Therapeutics is 1.08 times less risky than Dianthus Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Dianthus Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 2,125 in Denali Therapeutics on November 9, 2024 and sell it today you would earn a total of 128.00 from holding Denali Therapeutics or generate 6.02% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Denali Therapeutics vs. Dianthus Therapeutics
Performance |
Timeline |
Denali Therapeutics |
Dianthus Therapeutics |
Denali Therapeutics and Dianthus Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Denali Therapeutics and Dianthus Therapeutics
The main advantage of trading using opposite Denali Therapeutics and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
Dianthus Therapeutics vs. ON24 Inc | Dianthus Therapeutics vs. Paysafe | Dianthus Therapeutics vs. Cedar Realty Trust | Dianthus Therapeutics vs. Rackspace Technology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |